Finally, if brain fog coincides with dose escalation, discussing a slower titration schedule with your PlexusDx clinician may reduce the intensity of adjustment symptoms while maintaining safety and efficacy
The relationship between muscle mass and muscle strength in the elderly
Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
NICE guidance (NG69) recommends specific psychological therapies, including enhanced CBT (CBT-E), for eating disorders
Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene
Lancet Diabetes Endocrinol 8:535545